Xintela AB (publ) (STO:XINT)
0.2720
-0.0100 (-3.55%)
At close: Feb 26, 2026
Xintela AB Employees
Xintela AB had 13 employees as of December 31, 2024. The number of employees decreased by 8 or -38.10% compared to the previous year.
Employees
13
Change (1Y)
-8
Growth (1Y)
-38.10%
Revenue / Employee
227.46K SEK
Profits / Employee
-3.25M SEK
Market Cap
234.26M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 13 | -8 | -38.10% |
| Dec 31, 2023 | 21 | -4 | -16.00% |
| Dec 31, 2022 | 25 | - | - |
| Dec 31, 2020 | 17 | 2 | 13.33% |
| Dec 31, 2019 | 15 | 2 | 15.38% |
| Sep 30, 2019 | 15 | 2 | 15.38% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Magle Chemoswed Holding AB | 144 |
| Sprint Bioscience AB | 29 |
| Bio-Works Technologies AB | 29 |
| NextCell Pharma AB | 24 |
| Mendus AB | 20 |
| Intervacc AB | 15 |
| AlzeCure Pharma AB | 11 |
| Isofol Medical AB | 6 |